List of Excipients in API DIFLORASONE DIACETATE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing DIFLORASONE DIACETATE
Detailed excipient profiles for DIFLORASONE DIACETATE
Excipient focus: BUTYLATED HYDROXYTOLUENE
DIFLORASONE DIACETATE drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CETYL ALCOHOL
DIFLORASONE DIACETATE drug variants containing CETYL ALCOHOL
DIFLORASONE DIACETATE drug variants not containing CETYL ALCOHOL
Excipient focus: CITRIC ACID MONOHYDRATE
DIFLORASONE DIACETATE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: GLYCERYL MONOSTEARATE
DIFLORASONE DIACETATE drug variants containing GLYCERYL MONOSTEARATE
DIFLORASONE DIACETATE drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | diflorasone diacetate | 0168-0353 |
| PharmaDerm a division of Fougera Pharmaceuticals Inc | diflorasone diacetate | 10337-395 |
| ANI Pharmaceuticals Inc | diflorasone diacetate | 62559-365 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
DIFLORASONE DIACETATE drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: LANOLIN ALCOHOLS
DIFLORASONE DIACETATE drug variants containing LANOLIN ALCOHOLS
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing LANOLIN ALCOHOLS
Excipient focus: MINERAL OIL
DIFLORASONE DIACETATE drug variants containing MINERAL OIL
DIFLORASONE DIACETATE drug variants not containing MINERAL OIL
Excipient focus: PALM OIL
DIFLORASONE DIACETATE drug variants containing PALM OIL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing PALM OIL
Excipient focus: PEG-100 STEARATE
DIFLORASONE DIACETATE drug variants containing PEG-100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing PEG-100 STEARATE
Excipient focus: PETROLATUM
DIFLORASONE DIACETATE drug variants containing PETROLATUM
DIFLORASONE DIACETATE drug variants not containing PETROLATUM
Excipient focus: POLYOXYL 40 STEARATE
DIFLORASONE DIACETATE drug variants containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing POLYOXYL 40 STEARATE
Excipient focus: POLYSORBATE 60
DIFLORASONE DIACETATE drug variants containing POLYSORBATE 60
DIFLORASONE DIACETATE drug variants not containing POLYSORBATE 60
Excipient focus: PROPYLENE GLYCOL
DIFLORASONE DIACETATE drug variants containing PROPYLENE GLYCOL
DIFLORASONE DIACETATE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
DIFLORASONE DIACETATE drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-5292 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SORBITAN MONOSTEARATE
DIFLORASONE DIACETATE drug variants containing SORBITAN MONOSTEARATE
DIFLORASONE DIACETATE drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: SOYBEAN OIL
DIFLORASONE DIACETATE drug variants containing SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | diflorasone diacetate | 51672-1296 |
| Emerald Therapeutics LLC | diflorasone diacetate | 72919-549 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing SOYBEAN OIL
Excipient focus: STEARYL ALCOHOL
DIFLORASONE DIACETATE drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | diflorasone diacetate | 0168-0353 |
| PharmaDerm a division of Fougera Pharmaceuticals Inc | diflorasone diacetate | 10337-395 |
| ANI Pharmaceuticals Inc | diflorasone diacetate | 62559-365 |
| >Company | >Ingredient | >NDC |
DIFLORASONE DIACETATE drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
DIFLORASONE DIACETATE drug variants containing WATER
DIFLORASONE DIACETATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
